Your browser doesn't support javascript.
loading
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
Polverelli, Nicola; Elli, Elena M; Abruzzese, Elisabetta; Palumbo, Giuseppe A; Benevolo, Giulia; Tiribelli, Mario; Bonifacio, Massimiliano; Tieghi, Alessia; Caocci, Giovanni; D'Adda, Mariella; Bergamaschi, Micaela; Binotto, Gianni; Heidel, Florian H; Cavazzini, Francesco; Crugnola, Monica; Pugliese, Novella; Bosi, Costanza; Isidori, Alessandro; Bartoletti, Daniela; Auteri, Giuseppe; Latagliata, Roberto; Gandolfi, Lisa; Martino, Bruno; Scaffidi, Luigi; Cattaneo, Daniele; D'Amore, Fabio; Trawinska, Malgorzata M; Stella, Rossella; Markovic, Uros; Catani, Lucia; Pane, Fabrizio; Cuneo, Antonio; Krampera, Mauro; Semenzato, Gianpietro; Lemoli, Roberto M; Vianelli, Nicola; Breccia, Massimo; Russo, Domenico; Cavo, Michele; Iurlo, Alessandra; Palandri, Francesca.
  • Polverelli N; Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.
  • Elli EM; Haematology Division, San Gerardo Hospital, ASST Monza, Monza, Italy.
  • Abruzzese E; Division of Haematology, Ospedale S. Eugenio, Roma, Italy.
  • Palumbo GA; Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", University of Catania, Catania, Italy.
  • Benevolo G; Division of Haematology, Città della Salute e della Scienza Hospital, Torino, Italy.
  • Tiribelli M; Division of Haematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Bonifacio M; Department of Medicine, Section of Haematology, University of Verona, Verona, Italy.
  • Tieghi A; Department of Haematology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Caocci G; Department of Medical Sciences and Public Health, Haematology Unit, University of Cagliari, Cagliari, Italy.
  • D'Adda M; Division of Haematology, ASST Spedali Civili of Brescia, Brescia, Italy.
  • Bergamaschi M; Department of Internal Medicine (DiMI), Clinic of Haematology, IRCCS AOU San Martino-IST, Genova, Italy.
  • Binotto G; Unit of Haematology and Clinical Immunology, University of Padova, Padova, Italy.
  • Heidel FH; Internal Medicine II, Haematology and Oncology, Friedrich-Schiller-University Medical Center, Jena, Germany.
  • Cavazzini F; Division of Haematology, University of Ferrara, Ferrara, Italy.
  • Crugnola M; Division of Haematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Pugliese N; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Bosi C; Division of Haematology, AUSL di Piacenza, Piacenza, Italy.
  • Isidori A; Haematology and Stem Cell Transplant Center Marche Nord Hospital, Pesaro, Italy.
  • Bartoletti D; Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
  • Auteri G; Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
  • Latagliata R; Division of Cellular Biotechnologies and Haematology, University Sapienza, Roma, Italy.
  • Gandolfi L; Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.
  • Martino B; Division of Haematology, Azienda Ospedaliera "Bianchi Melacrino Morelli", Reggio Calabria, Italy.
  • Scaffidi L; Department of Medicine, Section of Haematology, University of Verona, Verona, Italy.
  • Cattaneo D; Haematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • D'Amore F; Unit of Haematology and Clinical Immunology, University of Padova, Padova, Italy.
  • Trawinska MM; Division of Haematology, Ospedale S. Eugenio, Roma, Italy.
  • Stella R; Division of Haematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Markovic U; Division of Haematology, AOU Policlinico-Vittorio Emanuele, University of Catania, Catania, Italy.
  • Catani L; Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
  • Pane F; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Cuneo A; Division of Haematology, University of Ferrara, Ferrara, Italy.
  • Krampera M; Department of Medicine, Section of Haematology, University of Verona, Verona, Italy.
  • Semenzato G; Unit of Haematology and Clinical Immunology, University of Padova, Padova, Italy.
  • Lemoli RM; Department of Internal Medicine (DiMI), Clinic of Haematology, IRCCS AOU San Martino-IST, Genova, Italy.
  • Vianelli N; Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
  • Breccia M; Division of Cellular Biotechnologies and Haematology, University Sapienza, Roma, Italy.
  • Russo D; Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.
  • Cavo M; Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
  • Iurlo A; Haematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Palandri F; Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
Br J Haematol ; 193(2): 356-368, 2021 04.
Article en En | MEDLINE | ID: mdl-33222197
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Neoplasias Primarias Secundarias / Mielofibrosis Primaria / Inhibidores de las Cinasas Janus Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged80 Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Neoplasias Primarias Secundarias / Mielofibrosis Primaria / Inhibidores de las Cinasas Janus Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged80 Idioma: En Año: 2021 Tipo del documento: Article